School of Medicine Homepage
Emory University Shield
  • About
    • Our Vision
    • Academic Departments
    • Our Leadership
    • Health Care Partnerships
    • Diversity, Equity, & Inclusion
    • Location
    • Supporting Our People
    • Our Faculty
    • History
    • News
    • Events
    • Contact Us
  • Education
    • Degree and Certificate Programs
    • Academic Departments
    • Residents & Fellows
    • Postdoctoral Training
    • Continuing Medical Education
    • Admissions
    • Cost and Financial Aid
    • Student Resources
  • Research
    • Research Innovation
    • Conducting Research
    • Core Facilities
    • Research Centers
    • Research Training
    • Academic Departments
    • Find a Researcher
    • Research News
  • Clinical Experience
    • Where We Work
    • Caring for a Diverse Population
    • Faculty Clinical Experience
    • Advanced Patient Care
    • Academic Departments
    • Community Learning
  • Giving
  • Directory

Directory section navigation

  • Faculty Profiles

Emory University School of Medicine

  • About
    • Sub link
      Our Vision
    • Sub link
      Academic Departments
    • Sub link
      Our Leadership
    • Sub link
      Health Care Partnerships
    • Sub link
      Diversity, Equity, & Inclusion
    • Sub link
      Location
    • Sub link
      Supporting Our People
    • Sub link
      Our Faculty
    • Sub link
      History
    • Sub link
      News
    • Sub link
      Events
    • Sub link
      Contact Us
  • Education
    • Sub link
      Degree and Certificate Programs
    • Sub link
      Academic Departments
    • Sub link
      Residents & Fellows
    • Sub link
      Postdoctoral Training
    • Sub link
      Continuing Medical Education
    • Sub link
      Admissions
    • Sub link
      Cost and Financial Aid
    • Sub link
      Student Resources
  • Research
    • Sub link
      Research Innovation
    • Sub link
      Conducting Research
    • Sub link
      Core Facilities
    • Sub link
      Research Centers
    • Sub link
      Research Training
    • Sub link
      Academic Departments
    • Sub link
      Find a Researcher
    • Sub link
      Research News
  • Clinical Experience
    • Sub link
      Where We Work
    • Sub link
      Caring for a Diverse Population
    • Sub link
      Faculty Clinical Experience
    • Sub link
      Advanced Patient Care
    • Sub link
      Academic Departments
    • Sub link
      Community Learning
  • Giving
  • Directory
  • Home School of Medicine Home
  • Directory

Profile

Robert McKeon PhD

  • Department of Cell Biology
    Associate Professor
  • rmckeon@emory.edu
  • Pubmed
  • Emory University School of Medicine
    Cell Biology
    Medical Education Building, Room PB-87
Head shot of Robert McKeon

Overview

Research in my lab is focused on examining the cellular response to central nervous system (CNS) injury. After damage to the CNS, injured axons fail to regenerate due to the formation of a non-neuronal glial barrier comprised predominantly of reactive astrocytes. The extracellular matrix of this astrogliotic tissue contains axon growth inhibitory chondroitin sulfate proteoglycans (CS-PGs) that are produced by reactive astrocytes. We have recently determined that two CS-PGs, neurocan and phosphacan, are localized to glial scars and that the astrocytic expression of neurocan is specifically upregulated by the injury-induced cytokine transforming growth factor- (TGF-). Immunoneutralization of TGF decreases neurocan expression by cultured astrocytes and enhances process outgrowth from hippocampal neurons. Importantly, new preliminary data demonstrates that in vivo immunoneutralization of TGF- enhances axonal regeneration in a model of indirect spinal cord injury. The ongoing goal of this project is to elucidate the regulation of astrocytic CS-PGs by examining TGF- mediated CS-PG gene expression. Our long-term goal continues to be directed towards developing strategies to block injury-induced expression of CS-PGs in hopes of promoting axonal regeneration after CNS injury.

Although reactive astrocytes inhibit axonal regeneration, their functions are quite diverse and, in some cases, neuroprotective. For example, reactive astrocytes secrete neurotrophic factors and re-establish ionic homeostasis. Astrocytes also remove the excitatory neurotransmitter glutamate from the extracellular space, thereby protecting neurons from excitotoxic-mediated cell death. Glutamate uptake, along with many other functions of reactive astrocytes, is energy dependent. In collaboration with the laboratory of Dr. Charles Buck, Dept. of Physiology, we have discovered that the expression of the adenine nucleotide translocator-1 (ANT1) is specifically upregulated in reactive astrocytes. ANT1 is an inner mitochondrial membrane protein that exchanges cytosolic ADP for mitochondrial ATP. These data provide the first evidence of an increased demand for energy placed on astrocytes under stress. The functional significance of ANT1 is demonstrated by a dramatic reduction in glutamate uptake by ANT1 null mutant astrocytes compared to genetically matched controls. Consistent with this finding, ANT1 null mutant astrocytes demonstrate decreased ATP levels. We are currently examining the significance of astrocytic ANT1 expression in vivo by determining neuronal survival in ANT1 null mutant versus genetically matched control mice after CNS injury. With the studies described above, these experiments will provide important mechanistic insight into the function of reactive astrocytes by examining the requirement for mitochondrial energy during biologically significant processes ranging from neuronal survival to axonal regenerative failure.

Academic Appointment

  • Associate Professor of Cell Biology, Emory University

Education

Degrees

  • PhD from University of Vermont
  • BA from College of the Holy Cross
  • M.S. from Duke University

Research

Publications

  • Targeted downregulation of N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase significantly mitigates chondroitin sulfate proteoglycan-mediated inhibition.
    Glia Volume: 59 Page(s): 981 - 996
    06/01/2011 Authors: Karumbaiah L; Anand S; Thazhath R; Zhong Y; McKeon RJ; Bellamkonda RV
  • Sustained delivery of activated Rho GTPases and BDNF promotes axon growth in CSPG-rich regions following spinal cord injury.
    PLoS One Volume: 6 Page(s): e16135
    01/24/2011 Authors: Jain A; McKeon RJ; Brady-Kalnay SM; Bellamkonda RV
  • Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury.
    Proc Natl Acad Sci U S A Volume: 107 Page(s): 3340 - 3345
    02/23/2010 Authors: Lee H; McKeon RJ; Bellamkonda RV
  • Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury.
    J Neurosci Volume: 26 Page(s): 9841 - 9850
    09/27/2006 Authors: Hsu J-YC; McKeon R; Goussev S; Werb Z; Lee J-U; Trivedi A; Noble-Haeusslein LJ
  • In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury.
    Biomaterials Volume: 27 Page(s): 497 - 504
    01/01/2006 Authors: Jain A; Kim Y-T; McKeon RJ; Bellamkonda RV
  • Axon regeneration in peripheral nerves is enhanced by proteoglycan degradation.
    Exp Neurol Volume: 195 Page(s): 278 - 292
    10/01/2005 Authors: Groves ML; McKeon R; Werner E; Nagarsheth M; Meador W; English AW
  • CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension.
    Mol Cell Neurosci Volume: 29 Page(s): 545 - 558
    08/01/2005 Authors: Gilbert RJ; McKeon RJ; Darr A; Calabro A; Hascall VC; Bellamkonda RV
  • Activation of protease-activated receptor-1 triggers astrogliosis after brain injury.
    J Neurosci Volume: 25 Page(s): 4319 - 4329
    04/27/2005 Authors: Nicole O; Goldshmidt A; Hamill CE; Sorensen SD; Sastre A; Lyuboslavsky P; Hepler JR; McKeon RJ; Traynelis SF
  • Special lecture: glial reactivity after damage: implications for scar formation and neuronal recovery.
    Clin Neurosurg Volume: 52 Page(s): 29 - 44
    01/01/2005 Authors: Hamill CE; Goldshmidt A; Nicole O; McKeon RJ; Brat DJ; Traynelis SF
  • Characterization of cellular and neurological damage following unilateral hypoxia/ischemia.
    J Neurol Sci Volume: 227 Page(s): 7 - 19
    12/15/2004 Authors: Olson EE; McKeon RJ
  • PAR-1 deficiency protects against neuronal damage and neurologic deficits after unilateral cerebral hypoxia/ischemia.
    J Cereb Blood Flow Metab Volume: 24 Page(s): 964 - 971
    09/01/2004 Authors: Olson EE; Lyuboslavsky P; Traynelis SF; McKeon RJ
  • TGF-beta1 induction of the adenine nucleotide translocator 1 in astrocytes occurs through Smads and Sp1 transcription factors.
    BMC Neurosci Volume: 5 Page(s): 1
    01/13/2004 Authors: Law AKT; Gupta D; Levy S; Wallace DC; McKeon RJ; Buck CR
  • Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport.
    Exp Neurol Volume: 181 Page(s): 149 - 158
    06/01/2003 Authors: Buck CR; Jurynec MJ; Gupta DK; Law AKT; Bilger J; Wallace DC; McKeon RJ
  • TIGR is upregulated in the chronic glial scar in response to central nervous system injury and inhibits neurite outgrowth.
    Mol Cell Neurosci Volume: 23 Page(s): 69 - 80
    05/01/2003 Authors: Jurynec MJ; Riley CP; Gupta DK; Nguyen TD; McKeon RJ; Buck CR
  • Antisense inhibition of neurocan promotes neurite outgrowth
    FASEB JOURNAL Volume: 15 Page(s): A1074 - A1074
    03/08/2001 Authors: Griffith RW; McKeon RJ
  • Transforming growth factor-beta regulates the astrocytic production of axon growth promoting and growth inhibitory molecules after CNS injury.
    JOURNAL OF NEUROCHEMISTRY Volume: 74 Page(s): S97 - S97
    01/01/2000 Authors: McKeon RJ; Griffith R
  • The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.
    J Neurosci Volume: 19 Page(s): 10778 - 10788
    12/15/1999 Authors: McKeon RJ; Jurynec MJ; Buck CR
  • Expression of full-length trkB receptors by reactive astrocytes after chronic CNS injury.
    Exp Neurol Volume: 148 Page(s): 558 - 567
    12/01/1997 Authors: McKeon RJ; Silver J; Large TH
  • Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars.
    Exp Neurol Volume: 136 Page(s): 32 - 43
    11/01/1995 Authors: McKeon RJ; Hke A; Silver J
  • beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.
    Exp Neurol Volume: 124 Page(s): 289 - 298
    12/01/1993 Authors: Canning DR; McKeon RJ; DeWitt DA; Perry G; Wujek JR; Frederickson RC; Silver J
  • Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes.
    J Neurosci Volume: 11 Page(s): 3398 - 3411
    11/01/1991 Authors: McKeon RJ; Schreiber RC; Rudge JS; Silver J
  • Cross-species septohippocampal transplants: ultrastructure of Thy-1.2-labeled donor fibers into the dentate gyrus.
    J Comp Neurol Volume: 312 Page(s): 242 - 250
    10/08/1991 Authors: Wells J; Vietje BP; McKeon RJ
  • Increase in acetylcholinesterase in the molecular layer of the dentate gyrus in the absence of septal inputs following selective granule cell lesions.
    Brain Res Volume: 503 Page(s): 317 - 321
    12/04/1989 Authors: McKeon RJ; Vietje BP; Wells J
  • Interactions between donor and host tissue following cross-species septohippocampal transplants.
    Exp Neurol Volume: 103 Page(s): 213 - 221
    03/01/1989 Authors: McKeon RJ; Vietje BP; Wells J
Read more publications Fewer publications
Directory
  • Faculty Profiles
Emory University Homepage

Contact & Location

Emory University School of Medicine
100 Woodruff Circle
Atlanta, GA  30322 USA
  • Contact Us
  • Maps & Directions
  • Careers

Information For

  • Alumni
  • Faculty & Staff
  • Patients
  • Residents & Fellows
  • Students
Support the School of Medicine School of Medicine Intranet
facebook facebook twitter twitter linkedin linkedin instagram instagram youtube youtube
© 2025 Emory University
  • Privacy Policy
  • Emergency Information
  • EEO Employer-Disability/Veteran Statements